Tiffany Tang
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Northeastern University(US)Chinese University of Hong Kong(HK)Universidad del Noreste(MX)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Single-cell and spatial transcriptomics, Viral-associated cancers and disorders, CAR-T cell therapy research
Most-Cited Works
- → SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group(2012)424 cited
- → Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma(2012)269 cited
- → JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma(2016)145 cited
- → Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype(2013)134 cited
- → Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis(2015)99 cited
- → Myocardial infarction in the C57BL/6J mouse(2004)